Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study
Xuexue Bai,1 Hao Xing,1 Ming Feng,1 Wenbin Ma,1 Shiyong Wang2 1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China; 2Department of Neurosurgery, The First Affiliated Hospital of Ji...
Saved in:
| Main Authors: | Bai X, Xing H, Feng M, Ma W, Wang S |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/dose-and-efficacy-of-bevacizumab-in-recurrent-high-grade-gliomas-a-ret-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
by: Qi Wan, et al.
Published: (2025-01-01) -
STING is significantly increased in high-grade glioma with high risk of recurrence
by: Meishi Zhong, et al.
Published: (2024-12-01) -
Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
by: Xue Zhang, et al.
Published: (2024-12-01) -
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy
by: Gu W, et al.
Published: (2025-01-01) -
Evaluation of the association between bevacizumab concentration and clinical outcomes in patients with breast cancer brain metastasis
by: Chih-Ning Cheng, et al.
Published: (2025-01-01)